Obviously, curing HIV is an open research question, but also the way to go about curing this retroviral infection is still unknown. When there is sustained virologic response, we know that the virus will come back if drugs are withdrawn. Exactly which niche of cells have integrated HIV into their genome, and how to identify them, is an active area of research at least as of about a year ago when I last looked into it (hint: probably macrophages and T cells).
The Berlin patient shows that cure is possible via treatments that also eradicate the bone marrow, but these are not generalizable across populations due to the high morbidity and mortality.
For prevention, vaccination that can generate antibodies such as the one in the article would be highly valuable. Less valuable but still very beneficial would be a long-lasting monoclonal antibody injection that can be given once a month (or ideally less often) to reduce the likelihood that high-risk individuals become infected.
For cure, I suspect that an approach which pairs replication suppression with genome editing tools, such as CRISPR, may ultimately prove successful in curing individuals of HIV.
Correct me if I'm wrong but I thought that patient got HIV back a year or two after the bone marrow transplant?
The question is whether all humans can produce this, or just some genotypes. If it's the latter, then yes, some people would have to take it as medicine and never stop.
Which is a problem since it would probably be a monoclonal antibody and those are the most expensive drugs to make. Like hundreds of thousands or even millions per year expensive (depending on what dose is needed).
If it really does cost millions per year the US couldn't afford it - it would cost over a trillion per year to treat everyone in the US, and more than 40 trillion to treat everyone (and that's just for the medicine).
(For comparison total healthcare spending in the US is 3 trillion.)
So better hope that either the price goes down, or that it only requires a limited course of treatment. Can you imagine a cure for HIV, and we can't afford it?
If the cure is proven, the society will likely be able to mobilize much more resources, particularly to scale up operations.
Special expertise can be trained to other biologists (the underemployment problem would be mitigated as well). More biologists could be trained. Likewise for factories, materials, etc. Monopolies can be broken.
What factors cannot be scaled up with such an approach? (Honest question. I do not know anything about antibody production.)
The first 3. Monopoly doesn't help I'm sure, but this drug class in inherently very expensive to produce, there's a reason there is little outcry over the prices charged.
It's extremely labor intensive, and very hard to scale up. They are also inherently dangerous, so there is a need for extreme purity. (See: https://en.wikipedia.org/wiki/TGN1412 for what a monoclonal antibody can do, you would not want that to happen by accident.)
As of right now this drug class remains the most expensive of all drugs, I would assume if it were possible to make it cheaper they would have.
But we'll only really know once the first generics enter the market.
You design the monoclonal antibody, figure out its sequence, deliver the sequence back into your own body (via some HIV-like virus), and now your body has an unlimited continuous access to the therapeutic.
Production of the therapeutic-delivering virus could be done in such a way as to produce a global scale for a small amount of money that would never need to be administered again. For example, in lab I can produce enough (lab quality) purified protein for a single one-time dose for a few thousand dollars and a week's work. On the other hand, I could produce enough therapeutic virus for dozens of people to forever produce their own versions of that same protein for a few hundreds dollars and an afternoon's work. This is very unlike any other 'drug' of the 20th century.
Ahh, of course they do. Thanks for the clarification :)
Either way this seems like an exciting result.
as an aside: Curiously, in the lab at least, most of those therapies are delivered using a 'gutted' version of HIV (precisely because it is so good at delivering genetic payloads to humans). So there's a pretty good chance you'd be using an engineered version of HIV's own machinery to deliver a permanent anti-HIV payload to the patient's genome.
It stops HIV from progressing in the body, holding it at bay. Someone with HIV would need to take this medicine for the rest of their lives. It doesn't actually cure it. (not denying that holding it at bay is a significant step forward)